Veracyte, Inc. (VCYT) Balance Sheet
As of 2026-06-30 (10-Q), Veracyte, Inc. (VCYT) reported total assets of $1.5B, total liabilities of $98.0M and shareholders' equity of $1.4B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $299.5M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
VCYTVeracyte, Inc.Follow VCYT — free
—
Price chart with a free account
- Market cap
- 3.9B
- P/E TTM
- 34.2
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.07 | 0.04 | 0.04 | 0.06 | 0.03 | 0.08 | 0.16 | 0.35 | 0.17 | 0.15 | 0.22 | 0.24 | 0.36 | 0.30 | |
| Short-term investments | — | — | — | — | — | — | — | — | — | — | — | — | 0.05 | — | |
| Receivables | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.04 | 0.04 | 0.04 | 0.05 | 0.04 | 0.05 | |
| Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | — | |
| Current assets | 0.08 | 0.04 | 0.05 | 0.07 | 0.05 | 0.10 | 0.19 | 0.38 | 0.24 | 0.25 | 0.29 | 0.37 | 0.49 | 0.57 | |
| Total assets | 0.08 | 0.06 | 0.08 | 0.10 | 0.08 | 0.12 | 0.28 | 0.46 | 1.19 | 1.16 | 1.11 | 1.30 | 1.41 | 1.49 | |
| Current liabilities | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.06 | 0.06 | 0.06 | 0.08 | 0.06 | 0.06 | |
| Long-term debt | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | |
| Short-term debt | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | |
| Total liabilities | 0.02 | 0.02 | 0.02 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.09 | 0.08 | 0.07 | 0.12 | 0.10 | 0.10 | |
| Shareholders' equity | 0.06 | 0.04 | 0.05 | 0.06 | 0.04 | 0.08 | 0.24 | 0.42 | 1.10 | 1.08 | 1.04 | 1.18 | 1.31 | 1.39 |
USD billions · SEC XBRL
Veracyte, Inc. — questions
- How much cash does Veracyte, Inc. have?
- $299.5M in cash and cash equivalents as of 2026-06-30.
- What are Veracyte, Inc.'s total assets?
- $1.5B as of 2026-06-30.
- What is Veracyte, Inc.'s shareholders' equity?
- $1.4B as of 2026-06-30.
Every figure on this page comes from Veracyte, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.